GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Market Cap

Shanghai Haohai Biological Technology Co (HKSE:06826) Market Cap : HK$15,345 Mil (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shanghai Haohai Biological Technology Co's share price for the quarter that ended in Mar. 2024 was HK$40. Shanghai Haohai Biological Technology Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 169 Mil. Therefore, Shanghai Haohai Biological Technology Co's market cap for the quarter that ended in Mar. 2024 was HK$6,748 Mil.

Shanghai Haohai Biological Technology Co's quarterly market cap declined from Sep. 2023 (HK$7,770 Mil) to Dec. 2023 (HK$6,911 Mil) and declined from Dec. 2023 (HK$6,911 Mil) to Mar. 2024 (HK$6,748 Mil).

Shanghai Haohai Biological Technology Co's annual market cap declined from Dec. 2021 (HK$9,055 Mil) to Dec. 2022 (HK$6,417 Mil) but then increased from Dec. 2022 (HK$6,417 Mil) to Dec. 2023 (HK$6,911 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Haohai Biological Technology Co's Enterprise Value for Today is HK$12,625 Mil.


Shanghai Haohai Biological Technology Co Market Cap Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Market Cap Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,376.50 8,358.72 9,054.83 6,416.69 6,910.52

Shanghai Haohai Biological Technology Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,064.93 5,481.22 7,769.86 6,910.52 6,748.28

Competitive Comparison of Shanghai Haohai Biological Technology Co's Market Cap

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Market Cap falls into.



Shanghai Haohai Biological Technology Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shanghai Haohai Biological Technology Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$40.3*171.477
=HK$6,911

Shanghai Haohai Biological Technology Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=HK$40*168.707
=HK$6,748

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (HKSE:06826) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shanghai Haohai Biological Technology Co Market Cap Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines